-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

703.O2.6 703. Cellular Immunotherapies: Basic and Translational: Cellular Immunotherapy: Preclinical and Translational Insights

Symposia: Cellular Immunotherapies: Basic and Translational Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, clinical trials, ALL, Lymphoid Leukemias, Translational Research, Lymphomas, non-Hodgkin lymphoma, Clinical Research, B Cell lymphoma, Plasma Cell Disorders, Diseases, immunology, Therapies, Lymphoid Malignancies, Biological Processes
Saturday, December 9, 2023: 4:00 PM-5:30 PM
Room 6A (San Diego Convention Center)
Moderators:
Zinaida Good, PhD, and R. Leo Sakemura, MD, PhD, Mayo Clinic
Disclosures:
Good: Kite Pharma, a subsidiary of Gilead Sciences: Research Funding; 10x Genomics, Inc.: Other: In-kind reagents and technical support; Standard BioTools, Inc.: Honoraria, Speakers Bureau; Mubadala Ventures: Consultancy; Atheneum Partners: Consultancy; Alpha Sights: Consultancy. Sakemura: Janssen: Honoraria.
4:00 PM

Varsha Sundaresan1*, Brigitte Senechal2*, Xiuyan Wang, PhD2*, Shubhra Kashyap1*, Erica Tong1*, Adarsh Joshi1*, Ajeeta Dash1*, Leopold Sellner1*, Sharon Chen1*, Devin McAvoy, BS3*, Kinga K Hosszu, PhD3*, Devanjan S Sikder2*, Isabelle Riviere1*, Michel Sadelain, MD PhD4, Jae H. Park, MD5 and Reshma Singh1*

1Takeda Development Center Americas, Inc., Lexington, MA
2Cell Therapy and Cell Engineering Facility, Memorial Sloan Kettering Cancer Center, New York, NY
3Department of Pediatrics and Immune Discovery & Modeling Service, Memorial Sloan Kettering Cancer Center, New York, NY
4Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY
5Cellular Therapeutics Service, Memorial Sloan Kettering Cancer Center, New York, NY

4:15 PM

Lydia Sarah Hui Lee, MD PhD1,2*, Wen Chean Lim, PhD3*, Catriona Mactier, MD4*, Juliana Dias Alves Pinto5*, Vitoria Pereira5*, Mhairi Vaughan5*, Louisa Green5*, Evie Lewin5*, John Garcia5*, Giulia Agliardi, PhD5*, Yashma Pathak6*, Riaz Jannoo6*, Leigh Wood2*, Bilyana Popova, MSc7*, Helen Holmes7*, Simon Thomas, PhD3*, Victoria Spanswick, PhD6*, William Wilson7*, Christopher Parrish, MBBChir, MRCP, FRCPath, MA, PhD8, Rakesh Popat2*, Claire Roddie, MD, PhD1,2*, Kwee Yong1,9 and Martin A. Pule, MD1,3*

1Research Department of Haematology, University College London Cancer Institute, London, United Kingdom
2Department of Haematology, University College London Hospitals NHS Foundation Trust, London, United Kingdom
3Autolus Therapeutics, London, United Kingdom
4University College London, London, United Kingdom
5Centre for Cell, Gene & Tissue Therapeutics, University College London Cancer Institute, London, United Kingdom
6UCL ECMC GCLP Facility, University College London Cancer Institute, London, United Kingdom
7Cancer Research UK & UCL Cancer Trials Centre, University College London Cancer Institute, London, United Kingdom
8Leeds Teaching Hospitals NHS Trust, Leeds Cancer Centre, Leeds, United Kingdom
9Department of Haematology, University College London, London, United Kingdom

4:30 PM

Meixian Huang1*, Mi-Ae Lyu1*, Ke Zeng, MD1*, Tara Sadeghi2*, Lucia Masarova, MD3, Christopher R. Flowers, MD, MS1 and Simrit Parmar, MBBS1

1Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
2Cellenkos Inc., Houston, TX
3Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

4:45 PM

Zhiliang Bai, PhD1*, Bing Feng, PhD2*, Susan E. Mcclory, MD, PhD3, Caroline Diorio, MD3, Ziran Zhao, PhD4, Li Tang, PhD2*, J. Joseph Melenhorst, PhD5, Carl June, MD6, Stephan Grupp, MD, PhD3 and Rong Fan, PhD1*

1Department of Biomedical Engineering, Yale University, New Haven, CT
2Institute of Bioengineering, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland
3Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA
4Center for ImmunoTherapy & Precision Immuno-Oncology, Cleveland Clinic, Cleveland, OH
5Cell Therapy and Immuno-Engineering Program, Center for ImmunoTherapy & Precision Immuno-Oncology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH
6Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA

5:00 PM

Yusuke Ito, MD, PhD1*, Seiichi Ohta, PhD2* and Yuki Kagoya, MD, PhD1*

1Keio University School of Medicine, Tokyo, Japan
2Institute of Engineering Innovation, The University of Tokyo, Tokyo, Japan

5:15 PM

Jufang Chang1*, Jack Landmann2*, Yangdon Tenzin1*, John Warrington3*, Mehmet Emrah Selli, PhD1*, Tien-Ching Chang3*, Michael Slade, MD, MSCI4, Deepesh Gupta, PhD3* and Nathan Singh, MD1

1Washington University School of Medicine, Saint Louis, MO
2Washington University School of Medicine, St. Louis, MO
3Washington University, St Louis, MO
4Division of Oncology, Washington University School of Medicine, Saint Louis, MO

*signifies non-member of ASH